Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID) granted, on August 3, 2026, 90,000 RSUs and a non-qualified stock option for 170,000 shares of Class A common stock as a material inducement for a new employee. The awards were issued under the company’s Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4), with the option priced at $2.12 per share and subject to time-based vesting over three and four years, contingent on continued employment.

News Explained

The August 3 grants create conditional rights to 90,000 RSUs and an option for 170,000 shares; if additional shares are issued when the awards vest or the option becomes exercisable, existing holders’ percentage ownership would decline.

Market Context

Bain Capital Life Sciences Investors, LLC recorded three purchases totaling 4,389,000 shares in the ...

Analysis

Bain Capital Life Sciences Investors, LLC recorded three purchases totaling 4,389,000 shares in the platform record. Against that insider-buying backdrop, the inducement grants remain primarily a hiring-related equity event; vesting depends on continued employment.

Key Figures

Restricted stock units: 90,000 RSUs Stock option: 170,000 shares Exercise price: $2.12 per share +4 more

7 metrics

Restricted stock units 90,000 RSUs Granted August 3, 2026 to a new employee

Stock option 170,000 shares Non-qualified option granted August 3, 2026

Exercise price $2.12 per share Equal to the closing price on the grant date

Initial option vesting 25% Vests on the first anniversary of the grant date

Monthly option vesting 1/48th Vests monthly after the first anniversary

RSU vesting period Three years RSUs vest annually over the stated period

Annual RSU vesting One-third Vests on each anniversary of the grant date

Historical Context

5 past events · Latest: Jul 23 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 23	Earnings date notice	Neutral	+0.0%	Scheduled second-quarter 2026 results release and webcast for August 7
Jun 10	Inducement grant	Neutral	+2.7%	60,000 RSUs granted to a new hire under the inducement plan
May 18	Offering pricing	Negative	+1.3%	Underwritten offering priced with shares, warrants, and possible additional proceeds
May 13	Quarterly earnings	Negative	-6.5%	First-quarter results included a widened net loss and reaffirmed 2026 guidance
May 06	Earnings date notice	Neutral	+1.2%	Scheduled first-quarter 2026 results release and webcast for May 13

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

RPID's prior inducement-grant announcement was followed by a 2.73% 24-hour gain, while its prior earnings release was followed by a -6.45% reaction.

Key Terms

restricted stock units, non-qualified stock option, inducement plan, nasdaq listing rule 5635(c)(4)

4 terms

restricted stock units financial

"grants on August 3, 2026, of 90,000 restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-qualified stock option financial

"and a non-qualified stock option to purchase 170,000 shares"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

inducement plan financial

"All such equity awards were made under the Company's Inducement Plan"

An inducement plan is a program a company creates to encourage employees or new hires to stay or join by offering special benefits or rewards. It’s like a company giving extra bonuses or perks to persuade someone to choose their job over others, helping the company attract and keep talented workers.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on August 3, 2026, of 90,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) and a non-qualified stock option to purchase 170,000 shares of Common Stock (the “Option”), all as a material inducement to employment for a new employee. All such equity awards were made under the Company’s Inducement Plan, as amended (the “Inducement Plan”) and were approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity awards are subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable stock option and RSU award agreements covering the grants.

The Option has an exercise price of $2.12 per share, which is equal to the closing price of Common Stock on its grant date. Twenty-five percent (25%) of the Option will vest and become exercisable on the first anniversary of its grant date, and 1/48th of the Option will vest and become exercisable each month thereafter, subject to such employee's continued employment on each vesting date.

The RSUs will vest annually over a three-year period, with one-third of the RSUs vesting on each anniversary of its respective grant date, subject to such employee's continued employment on each vesting date.

The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of the Company, or following a bona fide period of non-employment, as an inducement material to such individual's entering into employment with the Company, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.

About Rapid Micro Biosystems

Rapid Micro Biosystems Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on Twitter at @rapidmicrobio or on LinkedIn. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.

Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com

Media Contact:
media@rapidmicrobio.com

FAQ

What equity awards did Rapid Micro Biosystems (RPID) grant on August 3, 2026?

Rapid Micro Biosystems granted 90,000 restricted stock units and a non-qualified stock option for 170,000 shares. According to the company, these awards are a material inducement to employment for a new employee and were issued under its Inducement Plan.

What is the exercise price of the new stock option granted by Rapid Micro Biosystems (RPID)?

The stock option has an exercise price of $2.12 per share. According to Rapid Micro Biosystems, this price equals the closing price of its Class A common stock on the August 3, 2026 grant date, aligning with standard equity compensation practices.

How do the new Rapid Micro Biosystems (RPID) inducement stock options vest?

Twenty-five percent of the option vests on the first anniversary of the grant date. According to Rapid Micro Biosystems, the remaining 75% vests in equal monthly installments over the next three years, subject to the employee’s continued employment on each vesting date.

What is the vesting schedule for the 90,000 RSUs granted by Rapid Micro Biosystems (RPID)?

The 90,000 RSUs vest in three equal annual installments over three years. According to Rapid Micro Biosystems, one-third of the RSUs vests on each anniversary of the grant date, conditioned on the employee remaining employed on the applicable vesting date.

Why did Rapid Micro Biosystems (RPID) use its Inducement Plan for these August 2026 equity grants?

The company used its Inducement Plan to grant equity as a material inducement to hiring a new employee. According to Rapid Micro Biosystems, this plan is reserved for individuals not previously employed, consistent with Nasdaq Listing Rule 5635(c)(4).